Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OGT Strengthens Focus on Cancer Biomarkers

Published: Monday, October 21, 2013
Last Updated: Monday, October 21, 2013
Bookmark and Share
Oxford Gene Technology announce the appointment of Dr Bob Holland as Chief Medical Officer.

Dr Holland (57), is an expert in biomarker-driven drug development. He has an impressive clinical track record with over 25 years’ experience in the pharmaceutical industry, where he has contributed to the development of significant medicines in neuroscience and oncology. His long-standing interest in biomarkers led to the creation of an entirely new division at AstraZeneca - Personalised Healthcare & Biomarkers - which is dedicated to the application of molecular biology and imaging techniques to improve the discovery and development of new drugs. As VP and Head of this division, Dr Holland was instrumental in the generation of a pipeline in which 14 developmental drug programmes were matched with potential companion diagnostic tests.

Dr Holland will add considerably to OGT’s expertise in cancer profiling and biomarker development. He will lead in clinical matters across the range of OGT’s business, working with the R&D and commercial teams to design and implement clinical development programmes to expand OGT’s next generation sequencing and microarray cancer profiling solutions and advanced biomarker programmes in prostate and colorectal cancer. 

Commenting on his appointment, Dr Holland said, “The development and commercialisation of biomarkers to aid diagnosis and to personalise treatment, particularly in oncology, is something that I have had a continued and unwavering interest in for many years. OGT is at the forefront of this area of medicine and I look forward to joining the team to take the Company’s innovative genomic solutions through to the clinic.”

Dr Mike Evans, CEO, OGT said, “At OGT, we believe in finding the right people with the right expertise to spearhead our business. Bob is an expert in the clinical development of cancer biomarkers, which is a great fit with our strategic aims. His experience will help further OGT’s position in these areas. We are pleased to have Bob on board to help guide our expansion of the range of clinical genomic products and services across the diagnostic pathway.”

The appointment of Dr Holland is another key step in OGT’s commitment to tackle cancer through the development of innovative profiling and diagnosis tools. In May, OGT launched a 58-gene solid tumour profiling next-generation sequencing service to advance vital research into personalised cancer care for breast, prostate, ovarian, lung and colorectal cancer. In March, the Company was granted a license by The Institute of Cancer Research to develop and commercialise a new panel of diagnostic and prognostic microRNA markers for prostate cancer, and in February it signed an agreement with the Cancer Cytogenomics Microarray Consortium (CCMC) to design a whole genome, cancer-specific microarray which was launched in August.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OGT to Exhibit and Present at Molecular Medicine Tri-Con 2012
The conference will include an OGT presentation entitled “Integrated Biomarker Discovery: Multi-Method Approach to Enable Early Biomarker Success”, taking place on Tuesday 21st February at 15.50 in the Moscone North Convention Centre.
Friday, February 10, 2012
OGT Grants DNA Sequence Variation Licence to Biotype Diagnostics GmbH
The licence, which will remain valid for the lifetime of the patents, provides Biotype with certain rights with respect to SNP genotyping.
Tuesday, November 23, 2010
Scientific News
New Method Promises to Speed Development of Food Crops
A new study addresses a central challenge of transgenic plant development: how to reliably evaluate whether genetic material has been successfully introduced.
Study Validates Analysis of Copy Number Variation in Miniaturized Reaction Volumes
Data shows that accurate and reproducible CNV results can be produced with IntelliQube using the Array Tape® consumable.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Parallel Single-Cell Profiling
New single-cell genomics protocol allows researchers to study links between DNA modifications (methylation) and the activity of a gene.
Pathogens Found in Iceman's Gut
Scientists discover Helicobacter pylori in the contents of Ötzi’s stomach along with some unexpected insights into the coexistence of man and bacterium.
Diagnosing Cancer from a Single Drop of Blood
What if a physician could effectively diagnose cancer from one drop of a patient’s blood?
Tracing a Cellular Family Tree
New technique allows tracking of gene expression over generations of cells as they specialize.
Accelerating Protein Evolution
A new tool enables researchers to test millions of mutated proteins in a matter of hours or days, speeding the search for new medicines, industrial enzymes and biosensors.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!